Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilario Russo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Kidney International|March 21, 2026
The authors replySanjeev Sethi, Fernando C Fervenza, Ilario Russo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Monoclonal Gammopathy associates with Kidney Failure in ANCA-Associated VasculitisPoemlarp Mekraksakit, Maria J Vargas-Brochero, Ilario Russo, et al.
Kidney International|June 8, 2025
Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsyLadan Zand, Ilario Russo, Maria J Vargas-Brochero, et al.
Mayo Clinic Proceedings|March 6, 2026
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Mayo Clinic Proceedings|June 15, 2026
In Reply: Reassessing Cancer Attribution and Methodological Limitations in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass indexMaria J Vargas-Brochero, Ilario Russo, Tommaso Mazzierli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Kidney International|March 21, 2026
The authors replySanjeev Sethi, Fernando C Fervenza, Ilario Russo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Monoclonal Gammopathy associates with Kidney Failure in ANCA-Associated VasculitisPoemlarp Mekraksakit, Maria J Vargas-Brochero, Ilario Russo, et al.
Kidney International|June 8, 2025
Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsyLadan Zand, Ilario Russo, Maria J Vargas-Brochero, et al.
Mayo Clinic Proceedings|March 6, 2026
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Mayo Clinic Proceedings|June 15, 2026
In Reply: Reassessing Cancer Attribution and Methodological Limitations in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass indexMaria J Vargas-Brochero, Ilario Russo, Tommaso Mazzierli, et al.
Pageof 1